Cantor Fitzgerald’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
Other funds holding KPTI
ACA
Cantor Fitzgerald's KPTI Position: Q3 2026 in Review
Cantor Fitzgerald opened a new position in Karyopharm Therapeutics (KPTI) in Q3 2026: 173 shares worth $211. The stake represents ﹤0.01% of the portfolio and ranks #792 among its holdings.
92 funds tracked by Wall St. Rank hold KPTI as of Q3 2026.
- Cantor Fitzgerald held 173 shares of Karyopharm Therapeutics worth $211 as of Q3 2026.
- Karyopharm Therapeutics was a new Cantor Fitzgerald position in Q3 2026.
- Karyopharm Therapeutics made up ﹤0.01% of Cantor Fitzgerald's portfolio in Q3 2026, its #792 holding.
- 92 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q3 2026.
Based on Cantor Fitzgerald's 13F filing for Q3 2026, filed 16 Nov 2026.